172 related articles for article (PubMed ID: 25052497)
1. Primary neuroendocrine carcinoma of the breast: radiologic and pathologic correlation.
Yoon YS; Kim SY; Lee JH; Kim SY; Han SW
Clin Imaging; 2014; 38(5):734-8. PubMed ID: 25052497
[TBL] [Abstract][Full Text] [Related]
2. Clinical and radiologic features of neuroendocrine breast carcinomas.
Jeon CH; Kim SM; Jang M; Yun BL; Ahn HS; Kim SW; Kang E; Park SY
J Ultrasound Med; 2014 Aug; 33(8):1511-8. PubMed ID: 25063418
[TBL] [Abstract][Full Text] [Related]
3. A rare presentation of breast cancer.
Rappaport A; Van Steen A; Van Ongeval C
JBR-BTR; 2011; 94(2):75-7. PubMed ID: 21699039
[TBL] [Abstract][Full Text] [Related]
4. Primary neuroendocrine tumor of the breast: imaging features.
Chang ED; Kim MK; Kim JS; Whang IY
Korean J Radiol; 2013; 14(3):395-9. PubMed ID: 23690703
[TBL] [Abstract][Full Text] [Related]
5. MRI Features of Mucinous Cancer of the Breast: Correlation With Pathologic Findings and Other Imaging Methods.
Bitencourt AG; Graziano L; Osório CA; Guatelli CS; Souza JA; Mendonça MH; Marques EF
AJR Am J Roentgenol; 2016 Feb; 206(2):238-46. PubMed ID: 26797349
[TBL] [Abstract][Full Text] [Related]
6. Primary large cell neuroendocrine carcinoma of the breast: radiologic and pathologic findings.
Kim JW; Woo OH; Cho KR; Seo BK; Yong HS; Kim A; Kang EY
J Korean Med Sci; 2008 Dec; 23(6):1118-20. PubMed ID: 19119462
[TBL] [Abstract][Full Text] [Related]
7. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
[TBL] [Abstract][Full Text] [Related]
8. A rare case report of a primary large-cell neuroendocrine carcinoma of the breast with coexisting Paget disease.
Psoma E; Nikolaidou O; Stavrogianni T; Mavromati A; Lytras K; Xirou P; Koumbanaki M; Panagiotopoulou D
Clin Imaging; 2012; 36(5):599-601. PubMed ID: 22920370
[TBL] [Abstract][Full Text] [Related]
9. Whole-body MR or PET-CT?
Schmidt GP
Eur J Radiol; 2012 Sep; 81 Suppl 1():S142-3. PubMed ID: 23083566
[No Abstract] [Full Text] [Related]
10. Imaging of neuroendocrine tumors.
Tamm EP; Kim EE; Ng CS
Hematol Oncol Clin North Am; 2007 Jun; 21(3):409-32; vii. PubMed ID: 17548032
[TBL] [Abstract][Full Text] [Related]
11. Bilateral Neuroendocrine Carcinoma of Breast: A Case Report.
Neupane S; Dhakal S; Walawalakar S; Parajuli SB; Sapkota S
JNMA J Nepal Med Assoc; 2021 Dec; 59(244):1320-1322. PubMed ID: 35199786
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine differentiated breast carcinoma: imaging features correlated with clinical and histopathological findings.
Günhan-Bilgen I; Zekioglu O; Ustün EE; Memis A; Erhan Y
Eur Radiol; 2003 Apr; 13(4):788-93. PubMed ID: 12664118
[TBL] [Abstract][Full Text] [Related]
13. Tumor metabolism and perfusion ratio assessed by 18F-FDG PET/CT and DCE-MRI in breast cancer patients: Correlation with tumor subtype and histologic prognostic factors.
An YS; Kang DK; Jung YS; Han S; Kim TH
Eur J Radiol; 2015 Jul; 84(7):1365-70. PubMed ID: 25886700
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.
Sawicki LM; Grueneisen J; Schaarschmidt BM; Buchbender C; Nagarajah J; Umutlu L; Antoch G; Kinner S
Eur J Radiol; 2016 Feb; 85(2):459-65. PubMed ID: 26781152
[TBL] [Abstract][Full Text] [Related]
15. Treatment Response Evaluation of Breast Cancer after Neoadjuvant Chemotherapy and Usefulness of the Imaging Parameters of MRI and PET/CT.
An YY; Kim SH; Kang BJ; Lee AW
J Korean Med Sci; 2015 Jun; 30(6):808-15. PubMed ID: 26028936
[TBL] [Abstract][Full Text] [Related]
16. Ameloblastic carcinoma: a case report with radiological features of computed tomography and magnetic resonance imaging and positron emission tomography.
Matsuzaki H; Katase N; Hara M; Asaumi J; Yanagi Y; Unetsubo T; Hisatomi M; Konouchi H; Nagatsuka H
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jul; 112(1):e40-7. PubMed ID: 21458329
[TBL] [Abstract][Full Text] [Related]
17. Age-related structural and functional changes in the breast: multimodality correlation with digital mammography, computed tomography, magnetic resonance imaging, and positron emission tomography.
Abramson RG; Mavi A; Cermik T; Basu S; Wehrli NE; Houseni M; Mishra S; Udupa J; Lakhani P; Maidment AD; Torigian DA; Alavi A
Semin Nucl Med; 2007 May; 37(3):146-53. PubMed ID: 17418148
[TBL] [Abstract][Full Text] [Related]
18. Advances in breast imaging. Although mammography remains standard for breast cancer screening, several newer technologies are helping to fine-tune diagnosis.
Harv Womens Health Watch; 2010 May; 17(9):1-3. PubMed ID: 20593556
[No Abstract] [Full Text] [Related]
19. Myofibroblastoma of the breast in postmenopausal women: Two case reports with imaging findings and review of the literature.
Jung HK; Son JH; Kim WG
J Clin Ultrasound; 2020 Jun; 48(5):279-282. PubMed ID: 32030771
[TBL] [Abstract][Full Text] [Related]
20. Positron emission mammography: better than magnetic resonance mammography?
Schilling K
Eur J Radiol; 2012 Sep; 81 Suppl 1():S139-41. PubMed ID: 23083565
[No Abstract] [Full Text] [Related]
[Next] [New Search]
